Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CAIV-T versus TIV in children 6 to 59 months for influenza prevention
2004-000585-13Phase 3Completed
- Sponsor
- MedImmune
- Start
- Jun 2004
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of live attenuated influenza vaccine and influenza vaccine in influenza (2 arms), sponsored by MedImmune. Primary endpoints: Relative efficacy against culture-confirmed symptomatic influenza and Safety assessment. Started Jun 2004; status: completed.
02
Drugs
live attenuated influenza vaccineinfluenza vaccine
03
Conditions
influenza
Beyond the preview
Go deeper on 2004-000585-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2004-000585-13.